Clinical trial

Evaluation of Four Treatment Modalities in Prostate Cancer With Low or "Early Intermediate" Risk

NCT01717677

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

PROCEDURE · Unmapped registry intervention radical prostatectomy Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention percutaneous radiation therapy Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention permanent seed implantation Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Active Surveillance Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Evaluation of Four Treatment Modalities in Prostate Cancer With Low or "Early Intermediate" Risk

Design: INTERVENTIONAL · Status: TERMINATED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2012-10-01

PhaseNA

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Interventions

radical prostatectomyPROCEDURE

percutaneous radiation therapyRADIATION

permanent seed implantationRADIATION

Active SurveillancePROCEDURE

Sponsors & collaborators

Association of Urologic Oncology (AUO)lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01717677 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.